Quantitation of chromosome 1p and 19q deletions in glial tumours by interphase FISH on formalin-fixed paraffin-embedded tissue

Journal of Clinical Neuroscience

Volumn 13, Issue 1, 2006, Pages 96-101

  Gonzales, Michael ^a   Dale, Susan ^a   Susman, Marleen ^a   Mills, John ^a  

^a Tissupath Pty Ltd   (Australia)

Author keywords

1p 19q deletion; FISH; Glioma; Oligoastrocytoma; Oligodendroglioma

Indexed keywords

ARTICLE; ASTROCYTOMA; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME DELETION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; OLIGODENDROGLIOMA; PRIORITY JOURNAL;

BRAIN NEOPLASMS; CELL COUNT; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; GLIOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PARAFFIN EMBEDDING;

EID: 30344443648     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2005.06.004     Document Type: Article

References (28)

1. E.R. Laws, I.F. Parney, and W. Huang Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project J Neurosurg 99 2003 467 473
2. A.M. Stark, A. Nabavi, J.M. Medhorn, and U. Blomer Glioblastoma multiforme: report of 267 cases treated at a single institution Surg Neurol 63 2005 162 169
3. M.J. Bello, P.E. Leone, and J. Vaquero Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumours Int J Cancer 64 1995 207 210
4. G. Cairncross, K. Ueki, and M.C. Zlatescu Specific chromosomal losses predict chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas J Natl Cancer Inst 90 1998 1473 1479
5. J.S. Smith, B. Aldrete, and Y. Minn Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype Oncogene 18 1999 4144 4152
6. S.H. Bigner, M.R. Mathews, and B.K. Rasheed Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization Am J Pathol 155 1999 375 386
7. J.S. Smith, A. Perry, and T.J. Borell Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas and mixed oligoastrocytomas J Clin Oncol 18 2000 636 645
8. Y. Ino, M.C. Zlatescu, and H. Sasaki Long patient survival and therapeutic responses in histologically disparate high grade gliomas with chromosome 1p loss J Neurosurg 92 2000 983 990
9. G.S. Bauman, Y. Ino, and K. Veki Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas Int J Radiat Oncol Biol Phys 48 2000 825 830
10. E. Gelpi, I.M. Ambros, and P. Birner Fluorescent in situ hybridization on isolated tumour cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumour specimens Mod Pathol 16 2003 708 715
11. Y. Ino, R.A. Betensky, and M.C. Zlatescu Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis Clin Cancer Res 7 2001 839 845
12. J.D. Buckner, D. Gesme Jr., and J.R. O'Fallon Phase II trial of Procarbazine, Lomustine and Vincristine as initial therapy for patients with low grade oligodendroglioma or oligoastrocytoma: efficacy and association with chromosomal abnormalities J Clin Oncol 21 2003 251 255
13. K.B. Fallon, C.A. Palmer, and K.A. Roth Prognostic value of 19, 19q, 9p, 10q and EFGR-FISH analyses in recurrent oligodendrogliomas J Neuropathol Exp Neurol 63 2004 314 322
14. M.C. Schmidt, S. Antweiler, and N. Urban Impact of genotype and morphology on the prognosis of glioblastoma J Neuropathol Exp Neurol 61 2002 321 328
15. E. Burton, K. Lamborn, and B. Fenerstein Gene aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma Cancer Res 62 2002 6205 6210
16. M. Sabel, J. Reifenberger, R.G. Weber, G. Reifenberger, and H.P. Schmitt Long term survival of a patient with giant cell glioblastoma. Case report J Neurosurg 94 2001 605 611
17. K. Hoang-Xuan, L. Capelle, and M. Kujas Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions J Clin Oncol 22 2004 3133 3138
18. M.J. van den Bent, A.A. Taphoorn, and J. Brandes Phase II study of first line chemotherapy with temozolomide recurrent oligodendroglial tumours: the European Organization for Research and Treatment of Cancer Brain Tumour Group Study 26971 J Clin Oncol 21 2003 2525 2528
19. M.T. Harris, M. Rosenthal, D. Ashley, and L. Cher An Australian experience with temozolomide for the treatment of recurrent high grade gliomas J Clin Neurosci 8 2001 325 327
20. M.E. Hegi, A.-C. Diserens, and T. Gorlia MGMT gene silencing and benefit from temozolomide in glioblastoma N Engl J Med 352 2005 997 1003
21. C.E. Fuller, and A. Perry Fluorescence in situ hybridisation (FISH) in diagnostic and investigative neuropathology Brain Pathol 12 2002 67 86
22. P.F. Ambros, and I.M. Ambros Pathology and biology guidelines for resectable and unresectable neuroblastic tumours and bone marrow examination guidelines Med Pediatr Oncol 37 2001 492 504
23. G. Reifenberger, J.M. Kros, P.C. Burger, D.N. Louis, and V.P. Collins Oligodendroglioma P. Kleihues W.K. Cavenee Pathology and Genetics of Tumours of The Nervous System. World Health Organization Classification of Tumours 2000 IARC Press Lyon 56 69
24. S.J. Knight, C.M. Lese, and K.S. Precht An optimized set of human telomere clones for studying telomere integrity and architecture Am J Hum Genet 67 2000 320 332
25. G. Ragnarsson, G. Eiriksdottir, and J.T. Johannsdottir Loss of heterozygosity at chromosome 19 in different solid human tumours: association with survival Br J Cancer 79 1999 1468 1474
26. H.W. Yang, Y.Z. Chen, and J. Takita Genomic structure and mutational analysis of KIF1B gene which is homozygously deleted in neuroblastoma at chromosome 1p36.2 Oncogene 20 2001 5075 5083
27. A. Tikoo, S. Czekay, and C. Viars p190-A, a human tumour suppressor gene, maps to the chromosome region 19q13.3 that is reportedly deleted in some gliomas Gene 257 2000 23 31
28. R.M. Wolf, N. Draghi, and X. Liang p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumour suppressor encoded on human chromosome 19q13.2 Genes Dev 17 2003 476 487